
    
      This is a randomized, patient, investigator and sponsor blinded, placebo-controlled study in
      pregnant women with primary HCMV infection. The study has three periods: (I) screening (II)
      double-blinded placebo-controlled treatment and (III) post-delivery follow-up of women and
      neonates/infants. Pregnant women with confirmed primary HCMV infection will participate in
      periods I and II. Mothers and neonates/infants born to mothers enrolled in the study will
      participate in period III.
    
  